-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Poseida Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q2 2024.
- Poseida Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$31.4M, a 14.3% decline year-over-year.
- Poseida Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$113M, a 286% decline year-over-year.
- Poseida Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$123M, a 92.9% decline from 2022.
- Poseida Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$64M, a 48.8% increase from 2021.
- Poseida Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$125M, a 3.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)